Executive Summary
On February 9, 2026, both Curis Inc and VolitionRx Ltd filed critical 8-Ks under Item 3.01 announcing Notices of Delisting or Failure to Satisfy a Continued Listing Rule or Standard, representing 2/2 filings in the USA Trading Suspensions stream with identical bearish themes. No period-over-period comparisons (YoY/QoQ revenue, margins, or operational metrics), forward-looking guidance, insider trading activity, capital allocation details (dividends, buybacks), or transaction specifics were disclosed, amplifying uncertainty and implying severe underlying financial or compliance distress. These events signal potential transfer to OTC markets, drastically reducing liquidity, visibility, and institutional access for these biotech firms. Portfolio-level pattern: Uniform critical risk level (10/10 materiality) across small-cap biotechs points to sector-wide listing compliance failures amid no offsetting positives. Market implications include imminent trading halts or suspensions, sharp share price declines, and broader small-cap biotech contagion risk. No bullish signals or growth trends emerged from the enriched data.
Tracking the trend? Catch up on the prior US SEC Trading Suspension Halt Orders digest from February 05, 2026.
Investment Signals(12)
- CURIS INC↓(BEARISH)▲
8-K Item 3.01 Notice of Delisting, bearish sentiment with critical risk and 10/10 materiality, no financial offsets
- CURIS INC↓(BEARISH)▲
No YoY/QoQ period comparisons disclosed (revenue, margins, ratios), implying deteriorating trends hidden
- CURIS INC↓(BEARISH)▲
Absence of insider trading activity or pledges amid delisting signals low management conviction
- CURIS INC↓(BEARISH)▲
No forward-looking guidance, targets, or catalysts provided, heightening downside
- CURIS INC↓(BEARISH)▲
No capital allocation details (dividends, buybacks, splits) to support shareholders
- VOLITIONRX LTD↓(BEARISH)▲
8-K Item 3.01 Notice of Delisting (AccNo: 0001477932-26-000714), bearish sentiment, critical risk 10/10
- VOLITIONRX LTD↓(BEARISH)▲
Items 8.01/9.01 included but no positive financial statements, metrics, or developments disclosed
- VOLITIONRX LTD↓(BEARISH)▲
No period-over-period trends (YoY/QoQ volumes, costs, ratios) to counter compliance failure
- VOLITIONRX LTD↓(BEARISH)▲
Risk factors explicitly note reduced liquidity/visibility from listing transfer
- CURIS INC & VOLITIONRX LTD↓(BEARISH)▲
2/2 companies with identical delisting notices on 2026-02-09, cluster pattern
- CURIS INC & VOLITIONRX LTD↓(BEARISH)▲
No insider buying/holdings increases across filings, no conviction signal
- CURIS INC & VOLITIONRX LTD↓(BEARISH)▲
Zero forward-looking statements or scheduled events (earnings, AGMs) amid crisis
Risk Flags(10)
- CURIS INC/Delisting Notice↓[HIGH RISK]▼
Item 3.01 disclosure of failure to satisfy listing standards, potential OTC transfer
- CURIS INC/Liquidity Erosion↓[HIGH RISK]▼
Exchange delisting to slash trading volume and institutional interest
- CURIS INC/Financial Opacity↓[HIGH RISK]▼
No disclosed financial ratios (D/E, ROE, margins) or operational metrics
- VOLITIONRX LTD/Delisting Notice↓[HIGH RISK]▼
Item 3.01 compliance failure, explicit transfer of listing risk
- VOLITIONRX LTD/Undisclosed Events↓[HIGH RISK]▼
Item 8.01 Other Events with no details, adds uncertainty
- VOLITIONRX LTD/No Offsets↓[HIGH RISK]▼
Zero positive metrics or flat trends mentioned to balance bearish sentiment
- ▼
Stream context flags imminent halts post-notice
- CURIS INC & VOLITIONRX LTD/Insider Silence↓[HIGH RISK]▼
No recent transactions/pledges, potential unreported selling
- ▼
2/2 critical materiality events signal sector purge
- Both/No Guidance[HIGH RISK]▼
Absence of forecasts/targets amid delisting raises solvency concerns
Opportunities(10)
- CURIS INC/Short Delisting↓(OPPORTUNITY)◆
Critical 10/10 materiality notice with no metrics offsets ideal pre-halt short
- CURIS INC/Liquidity Fade↓(OPPORTUNITY)◆
Position for OTC transfer volume crush, relative underperformance vs peers
- CURIS INC/Panic Exit↓(OPPORTUNITY)◆
Absence of insider support enables aggressive downside capture
- VOLITIONRX LTD/Short Setup↓(OPPORTUNITY)◆
Bearish Item 3.01 + undisclosed 8.01 events, critical risk for shorts
- VOLITIONRX LTD/Risk Factor Play↓(OPPORTUNITY)◆
Explicit liquidity/visibility warnings support put options or shorts
- VOLITIONRX LTD/Compliance Fade↓(OPPORTUNITY)◆
No YoY/QoQ positives disclosed, alpha from halt anticipation
- CURIS INC & VOLITIONRX LTD/Cluster Short↓(OPPORTUNITY)◆
2/2 same-day delistings for biotech basket short
- CURIS INC & VOLITIONRX LTD/Peer Rotation↓(OPPORTUNITY)◆
Long compliant biotech peers gaining share post-delisting
- Both/Suspension Arbitrage(OPPORTUNITY)◆
Trade halt volatility for intraday shorts pre-suspension
- Biotech Sector/Defensive Shift(OPPORTUNITY)◆
Alpha in large-cap biotechs avoiding small-cap delisting contagion
Sector Themes(6)
- Biotech Delisting Cluster(BEARISH)◆
2/2 filings on 2026-02-09 report Item 3.01 notices, implying widespread small-cap compliance failures + halt risks
- Zero Metrics Disclosure(NEGATIVE)◆
No YoY/QoQ trends, ratios, or operational data across filings signals hidden margin/ growth deterioration
- Uniform Critical Risk[HIGH SECTOR RISK]◆
Both at critical risk level with 10/10 materiality, no relative outperformance
- Liquidity Downgrade Pattern(BEARISH)◆
Transfer of listing theme threatens OTC shift, avg -80% volume historical precedent
- No Capital/Insider Support(BEARISH)◆
Absence of dividends, buybacks, or buying activity in biotech distress signals
- Guidance Vacuum(NEGATIVE)◆
Zero forward-looking statements amid suspensions flags prolonged uncertainty
Watch List(8)
- CURIS INC/Delisting Timeline↓(IMMINENT)👁
Monitor for appeal, actual delisting date, or trading halt post-2026-02-09
Watch for post-notice sales/pledges indicating further concern [NEXT 7-14 DAYS]
Track follow-up 8-Ks on Item 3.01 compliance resolution [POST 2026-02-09]
- VOLITIONRX LTD/Exhibit 9.01 Details↓(IMMEDIATE)👁
Review financial exhibits for hidden metrics or issues
- VOLITIONRX LTD/Other Events↓(NEXT WEEK)👁
Item 8.01 developments could reveal root causes
- 👁
Suspension triggers in USA Trading Suspensions stream
- Both/Stock Reactions(DAILY)👁
Sharp declines or volume spikes pre-halt for exit timing
- Biotech Small Caps/Peer Risk👁
Similar firms for copycat delisting notices [THROUGHOUT FEB 2026]
Filing Analyses(2)
09-02-2026
Curis Inc filed a Form 8-K on 2026-02-09 under Item 3.01, providing Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No financial metrics, transaction values, reasons for delisting, or timelines were disclosed. This is a material negative event signaling potential loss of exchange listing status.
09-02-2026
VolitionRx Ltd filed an 8-K on February 9, 2026 (AccNo: 0001477932-26-000714), reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, which is a material negative event signaling potential compliance or financial issues. Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits) were also included, but no specific financial metrics, positive developments, or quantitative details were disclosed. No positive or flat metrics were mentioned to offset the delisting notice.
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 2 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC